2-[3,5-dimethyl-4-[(5-methyl-1,3-thiazol-2-yl)methyl]piperazin-1-yl]-6-fluoro-4-(2-methylpropyl)benzonitrile
C22H29FN4S — CID 171779960
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3,5-dimethyl-4-[(5-methyl-1,3-thiazol-2-yl)methyl]piperazin-1-yl]-6-fluoro-4-(2-methylpropyl)benzonitrile
2-[3,5-dimethyl-4-[(5-methyl-1,3-thiazol-2-yl)methyl]piperazin-1-yl]-6-fluoro-4-(2-methylpropyl)benzonitrile (PubChem CID 171779960) has the molecular formula C22H29FN4S and a molecular weight of 400.57 g/mol. Its IUPAC name is 2-[3,5-dimethyl-4-[(5-methyl-1,3-thiazol-2-yl)methyl]piperazin-1-yl]-6-fluoro-4-(2-methylpropyl)benzonitrile.
Molecular Properties
| Compound Name | 2-[3,5-dimethyl-4-[(5-methyl-1,3-thiazol-2-yl)methyl]piperazin-1-yl]-6-fluoro-4-(2-methylpropyl)benzonitrile |
|---|---|
| PubChem CID | 171779960 |
| Molecular Formula | C22H29FN4S |
| Molecular Weight | 400.57 g/mol |
| Exact Mass | 400.21 |
| IUPAC Name | 2-[3,5-dimethyl-4-[(5-methyl-1,3-thiazol-2-yl)methyl]piperazin-1-yl]-6-fluoro-4-(2-methylpropyl)benzonitrile |
| SMILES | Cc1cnc(CN2C(C)CN(c3cc(CC(C)C)cc(F)c3C#N)CC2C)s1 |
| InChI | InChI=1S/C22H29FN4S/c1-14(2)6-18-7-20(23)19(9-24)21(8-18)26-11-15(3)27(16(4)12-26)13-22-25-10-17(5)28-22/h7-8,10,14-16H,6,11-13H2,1-5H3 |
| InChIKey | FUJCMTVDHYKEFC-UHFFFAOYSA-N |
| XLogP | 4.76 |
| TPSA | 43.16 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 400.57 |
| LogP ≤ 5 | 4.76 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171779960 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.